Merials
Merials was a global animal health company, formed in 1997 as a joint venture between Merck (known as MSD outside the United States and Canada) and Sanofi-Synthélabo. The company's focus was on the research, development, manufacturing, and marketing of veterinary pharmaceuticals and vaccines for both companion animals and livestock. Merials' product portfolio included a wide range of solutions addressing common health concerns in animals, such as parasiticides, vaccines for infectious diseases, and treatments for chronic conditions.
Throughout its existence, Merials was recognized for its commitment to innovation in animal health. The company
In 2017, Merials was acquired by Boehringer Ingelheim, another leading animal health company. This acquisition resulted